Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Zang, Yali
add a person with the name Zang, Yali
 

Other publications of authors with the same name

The enhancement of low quality fingerprint based on fractional calculus mask., , , , and . ICB, page 164-169. IEEE, (2012)A novel measure of fingerprint image quality using Principal Component Analysis(PCA)., , , , and . ICB, page 170-175. IEEE, (2012)Multi-scale local binary pattern with filters for spoof fingerprint detection., , , , , , , and . Inf. Sci., (2014)Minutia handedness: A novel global feature for minutiae-based fingerprint matching., , , , , , and . Pattern Recognition Letters, 33 (10): 1411-1421 (2012)A score-level fusion method with prior knowledge for fingerprint matching., , , , , and . ICPR, page 2379-2382. IEEE Computer Society, (2012)Central focused convolutional neural networks: Developing a data-driven model for lung nodule segmentation., , , , , , , , and . Medical Image Analysis, (2017)Radiomics analysis potentially reduces over-diagnosis of prostate cancer with PSA levels of 4-10 ng/ml based on DWI data., , , , , , , , and . Medical Imaging: Computer-Aided Diagnosis, volume 10950 of SPIE Proceedings, page 109501Z. SPIE, (2019)Identifying cognitive impairment in type 2 diabetes with functional connectivity: a multivariate pattern analysis of resting state fMRI data., , , , , and . Medical Imaging: Biomedical Applications in Molecular, Structural, and Functional Imaging, volume 10137 of SPIE Proceedings, page 101370N. SPIE, (2017)Prediction of malignant and benign of lung tumor using a quantitative radiomic method., , , , , , and . EMBC, page 1272-1275. IEEE, (2016)Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy., , , , , and . EMBC, page 1268-1271. IEEE, (2016)